Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
5.20
+0.23 (4.63%)
At close: Mar 9, 2026, 4:00 PM EDT
5.21
+0.01 (0.19%)
After-hours: Mar 9, 2026, 6:33 PM EDT

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Jun '22 Jun '21 2020 - 2016
Market Capitalization
5922161133544113
Upgrade
Market Cap Growth
208.68%91.16%221.19%-19.99%-61.12%200.36%
Upgrade
Enterprise Value
406-4898-19-1449
Upgrade
Last Close Price
4.973.194.022.473.097.98
Upgrade
PS Ratio
536.19148.2878.656.49-11.23
Upgrade
PB Ratio
1.530.741.500.640.721.68
Upgrade
P/TBV Ratio
3.000.90147.820.640.721.68
Upgrade
EV/Sales Ratio
377.28-68.42--4.86
Upgrade
Debt / Equity Ratio
0.010.010.03-0.010.01
Upgrade
Net Debt / Equity Ratio
-0.70-0.77-0.09-0.80-0.90-0.93
Upgrade
Net Debt / EBITDA Ratio
1.863.460.175.169.0219.54
Upgrade
Net Debt / FCF Ratio
1.603.070.184.106.9419.59
Upgrade
Asset Turnover
0.000.010.02--0.25
Upgrade
Inventory Turnover
-----6.07
Upgrade
Quick Ratio
8.4612.530.6714.4725.3836.58
Upgrade
Current Ratio
8.6612.681.0817.0726.1837.37
Upgrade
Return on Equity (ROE)
-37.26%-42.82%-57.70%--9.79%-9.26%
Upgrade
Return on Assets (ROA)
-17.24%-19.02%-32.81%--5.95%-5.43%
Upgrade
Return on Capital Employed (ROCE)
-34.50%-20.70%-49.80%-16.00%-10.30%-5.00%
Upgrade
Earnings Yield
-18.36%-36.77%-41.23%-30.64%-16.57%-3.00%
Upgrade
FCF Yield
-18.51%-33.72%-33.68%-30.42%-18.17%-2.85%
Upgrade
Buyback Yield / Dilution
-35.71%-140.72%-88.38%-0.06%-36.73%-53.61%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.